Crestchem Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 3.00 Cr
as on 05-07-2024
- Company Age 33 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 110.35%
(FY 2023)
- Profit 22.26%
(FY 2023)
- Ebitda 10.06%
(FY 2023)
- Net Worth 33.67%
(FY 2023)
- Total Assets 45.38%
(FY 2023)
About Crestchem
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 526269.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Crestchem Limited India is Khyati Vyas as COMPANY SECRETARY. Binaben Patel, Jignesh Shah, Rajesh Mody, and Four other members serve as directors at the Company.
- CIN/LLPIN
L24100GJ1991PLC015530
- Company No.
015530
- Stock Symbol
BSE : 526269
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Apr 1991
- Date of AGM
24 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Crestchem?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Khyati Vyas  | Company Secretary | 01-Apr-2020 | Current |
| Dipak Patel | Managing Director | 01-Feb-2008 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Binaben Patel | Director | 25-Mar-2015 | Current |
| Jignesh Shah | Additional Director | 02-Feb-2024 | Current |
| Rajesh Mody | Director | 24-Aug-2004 | Current |
| Nirmit Patel | Director | 17-Jul-2023 | Current |
| Manojkumar Patel | Director | 01-Apr-2022 | Current |
| Nitinkumar Shah | Director | 14-Nov-2016 | Current |
Financial Performance of Crestchem.
Crestchem Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 110.35% increase. The company also saw a substantial improvement in profitability, with a 22.26% increase in profit. The company's net worth Soared by an impressive increase of 33.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crestchem?
In 2023, Crestchem had a promoter holding of 31.45% and a public holding of 68.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Crestchem?
Unlock and access historical data on people associated with Crestchem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crestchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crestchem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
